BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Merck Serono 

9, chemin des Mines
Case postale 54
Geneva    CH-1211  Switzerland
Phone: 41-22-414-3000 Fax: 41-22-731-2179


SEARCH JOBS


Industry
Biotechnology






 Company News
Auxogyn, Inc., Merck Serono Strike Eeva Test Pact 4/3/2014 7:10:56 AM    More...
Merck's Consumer Health Division Breaks $1 Billion Barrier By Incorporating Brands From Merck Serono 3/6/2014 6:55:54 AM    More...
Merck Serono Has Named Dr. John Orloff As Head Of Global Clinical Development 2/11/2014 1:44:40 PM    More...
Week in Review: BeiGene Co.,Ltd Out-Licenses Novel Cancer Drug to Merck Serono 11/18/2013 10:29:30 AM    More...
BeiGene Co.,Ltd, Merck Serono Add $232 Million+ R&D Deal To Growing Cancer Partnership 11/13/2013 6:46:05 AM    More...
Merck Serono and Kadimastem Sign Memorandum of Understanding (MOU) on Drug Screening and Discovery for Neurodegenerative Diseases 11/4/2013 9:50:53 AM    More...
Lead Discovery Center Announces Five-Year Strategic Partnership With Merck Serono 10/31/2013 9:55:22 AM    More...
Merck Serono Takes a Chance and Funds Four Academia MS Projects 10/9/2013 8:06:05 AM    More...
Merck Serono's Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-Type Patients When Compared With Bevacizumab: New Analysis of FIRE-3 AIO Study 9/30/2013 10:44:17 AM    More...
Ablynx (ABLYF) and Merck Serono Further Strengthen Their Collaboration on Co-Discovery and Co-Development of Nanobodies 9/26/2013 9:20:31 AM    More...
12345678910...

//-->